For patients facing rare and often debilitating neurological disorders, specialized treatments like Nulibry, Yorvipath, and Ingrezza offer potential relief and hope. These FDA-approved medications target …

MIPLYFFA* NOURIANZ NULIBRY NUPLAZID* NUZYRA ODACTRA* ORALAIR* OTEZLA* OXERVATE* PALFORZIA*

Neurological disorders often require complex and targeted treatment strategies, especially when dealing with rare or serious conditions. Medications like Nulibry, Yorvipath, and Ingrezza are designed to …

Nulibry and Yorvipath are typically used in pediatric or rare disease contexts, while Ingrezza sees broader use across adult populations managing mental health conditions. How These Treatments …

When it comes to treating rare neurological disorders, breakthroughs in medicine like Nulibry, Yorvipath, and Ingrezza are changing the landscape of care. These therapies offer new hope for patients living …

Feb 22, 2026 · Exclusion Criteria: Treatment of acute or breakthrough nausea and vomiting Used in anthracycline or cyclophosphamide-based chemotherapy (Akynzeo injection only)

Please reference the Self-Administered or Provider-Administered Specialty drug list or medication guide for Prior Authorization information.

Specialty drugs may require preauthorization and may need to be obtained from CVS Specialty. Contact CVS Specialty toll-free at 1-800-237-2767 for Specialty Pharmacy service. For Your Information: This …

Medicaid/CHIP Prior Authorization Criteria Information Medicaid/CHIP Prior Authorization Criteria Information

AllADRENERGICSALCOHOL AND DRUG CESSATION AGENTALDOSTERONE ANTAGONISTSALLERGENSALPHA-2 ADRENERGIC AGONISTALZHEIMER'S …